What is the definition of poor R-wave progression on an electrocardiogram (ECG)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Definition of Poor R-Wave Progression on ECG

Poor R-wave progression (PRWP) is defined as an R-wave amplitude ≤ 0.3 mV (≤ 3 mm) in lead V3 AND an R-wave amplitude in lead V2 that is less than or equal to the R-wave amplitude in lead V3.

This is the most commonly applied and validated definition in clinical practice and research 1, 2.

Understanding the Normal R-Wave Pattern

Normally, the R-wave amplitude progressively increases from V1 through V4-V5 as the precordial leads move from the right ventricle toward the left ventricle. This reflects the normal electrical forces generated by left ventricular depolarization. When this expected progression is absent or diminished, it constitutes PRWP.

Alternative Diagnostic Criteria

While the primary definition above is most widely used, some sources apply slightly different thresholds:

  • Commonly used clinical criteria: R-wave ≤ 2 mm in leads V3 or V4 3
  • Marquette criteria: More stringent criteria that identify approximately 0.5% of the general population versus 1.8% with the commonly used criteria 3

The definition requiring RV3 ≤ 3 mm with RV2 ≤ RV3 appears to be the most validated across multiple studies and populations 1, 2.

Clinical Significance and Prevalence

PRWP occurs in approximately 2.7% of men and 7.0% of women in the general population, making it significantly more common in women 2. This finding carries prognostic implications:

  • In the general population: PRWP is associated with increased all-cause mortality (HR 2.00 in women, HR 1.69 in men) and cardiovascular mortality (HR 3.02 in women) 2
  • In patients with coronary artery disease: PRWP shows stronger association with sudden cardiac death (HR 2.62) and cardiac mortality (HR 1.71) 1
  • After anterior MI: PRWP correlates with larger infarct size and lower left ventricular ejection fraction 4

Critical Pitfalls to Avoid

Electrode misplacement is the most common technical cause of apparent PRWP and must be excluded before attributing clinical significance 5. Specifically:

  • Superior misplacement of V1 and V2 (in the 2nd or 3rd intercostal space instead of the 4th) reduces R-wave amplitude by approximately 0.1 mV per interspace, creating false PRWP or mimicking anterior infarction 5
  • Vertical electrode placement pattern (rather than horizontal) commonly produces artifactual PRWP 5
  • Always verify V1 and V2 are placed in the 4th intercostal space at the sternal borders, and V4 is in the 5th intercostal space at the midclavicular line, with V5 and V6 following the horizontal plane of V4 5

Other Causes of PRWP

Beyond electrode misplacement, PRWP may reflect:

  • Anterior myocardial infarction (most important pathological cause)
  • Left ventricular hypertrophy
  • Left bundle branch block
  • Chronic obstructive pulmonary disease with low diaphragm position 5
  • Normal variant, particularly with low cardiothoracic ratio 3
  • Diabetic cardiomyopathy (associated with diastolic dysfunction) 6

Important caveat: The positive predictive value of PRWP for coronary artery disease in asymptomatic general population screening is only 7.3%, making routine additional cardiac testing of questionable value in the absence of other clinical indicators 3.

References

Related Questions

What is the clinical significance of poor R‑wave progression on a 12‑lead ECG and how should it be evaluated and managed?
What is the BMI for a 101‑kg, 162‑cm individual?
In a 17-year-old with dyspnea and chest pain, a normal electrocardiogram (ECG) and normal chest radiograph, which laboratory tests should be ordered?
What is the metabolic equivalent (MET) for climbing a single flight of stairs?
How many milliliters of a 2 mg/mL solution are needed to administer a 0.5 mg dose?
What is the appropriate management of severe constipation lasting six days in an elderly female?
What is the definition of arrest of dilation?
In a 59‑year‑old male with hypertension and chronic hepatitis B infection who presents with tense, hemorrhagic ascites, anemia, thrombocytopenia, prolonged prothrombin time/INR, elevated AST and bilirubin, low albumin, impaired renal function, and ultrasound evidence of cirrhosis, what is the problem representation, the major clinical syndromes, the underlying pathophysiology, a complete differential diagnosis, the most likely diagnosis, does the hemorrhagic ascites suggest hepatocellular carcinoma, is hepatorenal syndrome present, what are the Child‑Pugh class and MELD score, and what evidence‑based management, additional diagnostic tests, hospital orders, and short‑ and long‑term treatment plan should be recommended according to Harrison’s Internal Medicine and AASLD cirrhosis guidelines?
What ketamine‑propofol (ketofol) bolus and infusion dosing regimen should be used for an average 70‑kg adult without severe cardiac or hepatic disease?
In a 59-year-old male with hypertension and chronic hepatitis B presenting with tense ascites, lower‑extremity edema, and dyspnea, what is the problem representation, major clinical syndromes, pathophysiology, differential diagnosis, most likely diagnosis, whether hemorrhagic ascites suggests hepatocellular carcinoma, evaluation for hepatorenal syndrome, Child‑Pugh class, MELD score, and the evidence‑based short‑ and long‑term management plan according to Harrison's Internal Medicine and AASLD cirrhosis guidelines?
What is the equivalent oral dose of N‑acetylcysteine for a patient receiving 1.2 g intravenously every 12 hours for contrast‑induced nephropathy prophylaxis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question